Literature DB >> 33068694

Development and in vitro evaluation of mucoadhesive gelatin films for the vaginal delivery of econazole.

Luisa Stella Dolci1, Beatrice Albertini2, Maria Francesca Di Filippo3, Francesca Bonvicini4, Nadia Passerini1, Silvia Panzavolta3.   

Abstract

Several strategies have been explored to obtain effective econazole nitrate (ECN) concentrations at the site of application for a prolonged time. In this paper, different gelatin-based film formulations for vaginal application were investigated, containing ECN (10% w/w with respect to gelatin) as pure drug or as drug-solid dispersions (SD). For the production of SD, different polymers were evaluated: polyvinylpyrrolidone (PVP), Soluplus® (polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer) and Gelucire® 50/13 (mixture of mono-, di- and triglycerides of fatty acids, esters of PEG 1500 and free PEG). Gelucire®-SD showed the best solubility enhancement, increasing 9.2 times the ECN solubility in pH 4.5 solution respect to pure drug; DSC and XRD analysis confirmed the crystalline form of the drug. XRD results evidenced that all gelatin-based films, containing either the drug or the SD, underwent the topotactic transformation of ECN into crystalline econazole (EC), owing to a strong interaction between the drug and the gelatin. Films containing Gelucire®-based SD displayed lower brittleness and rigidity with respect to the other samples; moreover they demonstrated good structural integrity after 24 h of incubation in the acidic solution (swelling degree of about 350%). Then, Gelucire®-SD based films were compared with the corresponding formulations cross-linked by genipin (2% w/w). The addition of genipin did not interfere with the drug-gelatin interaction. Gelucire®-SD based films showed similar release profiles to neat gelatin films, enhancing the drug release in the first 5 h and controlling the EC release over time, avoiding the use of a crosslinking additive. Finally, gelatin films containing Gelucire® solid dispersion displayed good adhesiveness and anti-Candida activity. Overall, results support the potential use of this film formulation as noncytotoxic EC delivery system for the treatment of vaginal candidiasis.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Controlled release; Econazole; Econazole nitrate (pubChem CID: 68589); Gelatin films; Gelucire® 53/10 (a mixture of mono-, di- and triglycerides, mainly mono- and diesters of palmitic (C16) and stearic (C18) acids), esters of PEG 1500 and also free PEG); Genipin; Kollidon®30 (polyvinylpyrrolidone); Kollidon®VA64 (polyvinylpyrrolidone-vinyl acetate); Solid dispersion; Solubility; Soluplus® (polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer: PCL-PVAc-PEG),; Solvent casting; Type A gelatin; Vaginal delivery

Mesh:

Substances:

Year:  2020        PMID: 33068694     DOI: 10.1016/j.ijpharm.2020.119979

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Toxicity Assessment of Resveratrol Liposomes-in-Hydrogel Delivery System by EpiVaginalTM Tissue Model.

Authors:  May Wenche Jøraholmen; Pauliina Damdimopoulou; Ganesh Acharya; Nataša Škalko-Basnet
Journal:  Pharmaceutics       Date:  2022-06-17       Impact factor: 6.525

Review 2.  Recent Advances in Polymer-Based Vaginal Drug Delivery Systems.

Authors:  Tomasz Osmałek; Anna Froelich; Barbara Jadach; Adam Tatarek; Piotr Gadziński; Aleksandra Falana; Kinga Gralińska; Michał Ekert; Vinam Puri; Joanna Wrotyńska-Barczyńska; Bozena Michniak-Kohn
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.